Literature DB >> 1115931

Measurement of fibrinogen-fibrin-related antigen in serum as aid to diagnosis of deep vein thrombosis in outpatients.

D A Tibbutt, C N Chesterman, M J Allington, E W Williams, T Faulkner.   

Abstract

A study of serum levels of fibrinogen-fibrin-related antigen (F.R.-antigen) in outpatients presenting with clinical features suggesting deep vein thrombosis was undertaken. A raised serum level of this antigen (greater than 12 mg/1) is strong evidence in favour of the diagnosis of deep vein thrombosis. It is virtually conclusive evidence if other known causes of a raised level of the antigen are absent. On the other hand, a normal serum level of F.R.-antigen does not exclude even extensive thrombosis, and other objective techniques are required to substantiate the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1115931      PMCID: PMC1672354          DOI: 10.1136/bmj.1.5954.367

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  An immunological method for demonstrating fibrin degradation products in serum and its use in the diagnosis of fibrinolytic states.

Authors:  H C FERREIRA; L G MURAT
Journal:  Br J Haematol       Date:  1963-07       Impact factor: 6.998

2.  Association of fibrinogen-fibrin-related antigen (F.R.-antigen) with postoperative deep-vein thrombosis and systemic complications.

Authors:  E H Wood; C R Prentice; G P McNicol
Journal:  Lancet       Date:  1972-01-22       Impact factor: 79.321

3.  125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis.

Authors:  V V Kakkar; A N Nicolaides; J T Renney; J R Friend; M B Clarke
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

4.  Prognostic value of serum fibrinogen-related antigen levels after myocardial infarction.

Authors:  A V Simmons; M A Sheppard; R Sibbald; G Tate; B E Roberts
Journal:  Br Heart J       Date:  1973-10

5.  Fibrin split products in acute pulmonary embolism.

Authors:  F D Rickman; R Handin; J P Howe; J S Alpert; L Dexter; J E Dalen
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

6.  Detection of fibrin(ogen) degradation products by a latex clumping method.

Authors:  M J Allington
Journal:  Scand J Haematol Suppl       Date:  1971

7.  Detection of venous thrombosis in the legs.

Authors:  P Atkins; L A Hawkins
Journal:  Lancet       Date:  1965-12-11       Impact factor: 79.321

8.  Clinical experience with determination of fibrinogen degradation products.

Authors:  U Hedner; M Nilsson
Journal:  Acta Med Scand       Date:  1971-06

9.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

10.  Spontaneous fibrinolysis in pulmonary embolism.

Authors:  J E Wilson; E P Frenkel; A K Pierce; R L Johnson; E R Winga; G C Curry; D S Mierzwiak
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.